fda approve mdma for ptsd

    Before Jan 1, 2027

    fda approve mdma for ptsd. Best Yes near 16¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 16¢ · Best No: 90¢ · 1 platform

    • Kalshi: Yes 16¢ / No 90¢
    TRADING OPEN

    Before Jan 1, 2027

    Volume

    $997

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jan 1, 2027

    ~109 days left

    Category

    Culture

    16¢CHANCE OF YES15%85%
    Yes
    16¢
    Kalshi
    No
    90¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    16¢
    No
    90¢
    Vol
    $997
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 16¢: exit costs ~0.94¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jan 1, 2027
    Time Left109 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In